Electronic media in prescription drug labelling guidance: Submission and assessment

Electronic media in prescription drug labelling guidance: Submission and assessment You can make the initial request to incorporate a link to an electronic platform on a prescription drug label through existing submission pathways including a prescription drug's: initial application for market authorization ((A)NDS or DINA/DINB) and the post-market application procedure (S(A)NDS or DINA/DINB). 2023-11-01 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetyelectronic mediaprescription drug labellingsubmission and assessment Electronic media in prescription drug labelling guidance: Submission and assessmentHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/electronic-media-prescription-drug-labelling/submission-assessment.html Electronic media in prescription drug labelling guidance: Submission and assessmentHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/participation-public-consultations/medicaments/utilisation-medias-electroniques-etiquettes-medicaments-ordonnance/presentation-evaluation.html

You can make the initial request to incorporate a link to an electronic platform on a prescription drug label through existing submission pathways including a prescription drug's: initial application for market authorization ((A)NDS or DINA/DINB) and the post-market application procedure (S(A)NDS or DINA/DINB).

Data and Resources

Similar records